… Normal stem cells and cancer stem cells appear to express … enable cancer stem cells to
resist current cancer therapies 25,… malignant stem cells can be determined by treatment of cells …

… the cancer stem cell and its dysregulated self-renewal, our therapies for treating … implications
for the way we study, diagnose and treat cancer if the same populations of cancer cells are …

… therapies (chemotherapy, radiotherapy) and the resistant mechanisms inherent in CSCs
and the micronvironment; and discuss the multiple therapeutic implications of targeting CSCs. …

… Evidence has shown that cancer stem cells (CSCs), a sub-population of cells that share
many common characteristics with somatic stem cells (SSCs), contribute to this therapeutic …

… target of conventional therapies. Moreover, certain cytokines – such as IFN-α – appear to
modulate SP and stem cell functions, and this associates with remarkable therapeutic activity in …

… suggests that therapeutic resistance and metastasis of cancer are mainly driven by a unique
subpopulation of tumor cells, termed cancer stem cells (CSCs), or cancer-initiating cells (…

… Cell therapy can also be achieved via ICV administration. For instance, stem cells genetically
modified to release factors with antitumor effects have also been demonstrated to be …

… subpopulations of cancer cells with increased renewal capacity and the ability to recapitulate
the heterogeneity found in primary tumors, which are referred to as cancer stem cells (CSCs…

Mesenchymal stem cells (MSCs) are a prototypical adult stem cell with capacity for self-renewal
and differentiation with a broad tissue distribution. Initially described in bone marrow, …

… Stem cells, which enhance wound healing and counteract systemic inflammation, now offer
potential therapies for … seeks to illustrate applications of stem cell therapy to burn care and to …